Lawrence Banta, MD
Psychiatry · Caldwell, IDNPI 1568440295
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,503 of the $2,811 with a category attached, or 89.0%. It is spread thinly across 23 manufacturers, the largest accounting for just 15.0% — the pattern of someone who eats at a lot of different presentations. Among psychiatry clinicians in ID with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 167 payments — averaging $16.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alkermes, Inc.$421
- Otsuka America Pharmaceutical, Inc.$254
- Teva Pharmaceuticals USA, Inc.$236
- Johnson & Johnson$234
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$224
- Sunovion Pharmaceuticals Inc.$220
- plus $1K from 17 others
What the payments were for
- Food & beverage$2,50389%
- Education$30811%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$2,811 in reported general payments places this provider in the 90th percentile of 98 psychiatry providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega SustennaPaliperidone Palmitate | 31 | $65,170 |
| AristadaAripiprazole Lauroxil | 19 | $59,100 |
| Abilify MaintenaAripiprazole | 13 | $36,750 |
| TrintellixVortioxetine Hydrobromide | 41 | $21,319 |
| CaplytaLumateperone Tosylate | 13 | $21,253 |
| VraylarCariprazine Hcl | 13 | $17,888 |
| Lurasidone Hcl | 60 | $17,065 |
| EliquisApixaban | 30 | $8,929 |
| Aripiprazole | 104 | $8,611 |
| Paliperidone ErPaliperidone | 23 | $7,242 |
| Chlorpromazine Hcl | 15 | $5,928 |
| BelsomraSuvorexant | 14 | $5,925 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 47 | $5,890 |
| LoxapineLoxapine Succinate | 33 | $3,560 |
| Carbamazepine ErCarbamazepine | 31 | $3,482 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonInvega Sustenna | $234 | $65,17031 claims |
| Alkermes, Inc.Aristada | $421 | $59,10019 claims |
| Otsuka America Pharmaceutical, Inc.Abilify Maintena | $254 | $36,75013 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $124 | $21,31941 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $224 | $21,25313 claims |
| AbbVieVraylar | $141 | $17,88813 claims |
| MerckBelsomra | $63 | $5,92514 claims |
| Teva Pharmaceuticals USA, Inc.Loxapine | $236 | $3,56033 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 98 psychiatry providers in Idaho.
Other psychiatry in Caldwell
- Colt KenningtonCaldwell$1K
- Sandra LareCaldwell$791
- Larry KimseyCaldwell$767
- Alfred BremCaldwell$590
- Richard MontgomeryCaldwell$305
- Craig DennyIdaho Falls$10K
- Linda CarterPocatello$9K
- Janet GilbreathNampa$9K
- Olurotimi AshayeMeridian$8K
- Thomas HolmesLewiston$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.